ORVION Lean GLP1
Our upcoming compounded Semaglutide pen, the same GLP-1 molecule as Wegovy®, prepared by a UAE-licensed compounding pharmacy at a fraction of the branded price. Launching soon.
How ORVION Lean GLP1 works
ORVION Lean™ is our forthcoming compounded Semaglutide pen, currently in final validation with our UAE-licensed compounding partner. It uses the same GLP-1 receptor agonist molecule as Wegovy®, with the same titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly), at a meaningfully lower price point than the branded option. Designed for patients who want a Semaglutide protocol but find Wegovy® cost-prohibitive or hard to source consistently. Once available, your Orvion physician will be able to switch you between ORVION Lean™ and ORVION Forma™ (Tirzepatide) based on tolerability and response. Join the waitlist below and we will notify you the moment it goes live.
Ready when you are.
A licensed UAE doctor is one message away. Confidential, fast, no clinic visit needed.